- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01164137
Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of Care (CMR)
February 12, 2013 updated by: Westview Physician Collaborative
Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of Care: to Develop and Test a Community-based Medication Reconciliation Program and a Risk Prediction Model That Identifies High-risk Patient Groups
This initiative aims to decrease the risk of medication errors at the hospital-community interface as well as health system utilization following hospital discharge by implementing a pharmacist-led medication reconciliation in the patients' home within 72 hours of hospital discharge.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The goals of this initiative are to decrease the risk for medication errors at the hospital community interface of care, thus decreasing preventable adverse drug events and preventable drug-related health system utilization following hospital discharge. This initiative has four objectives that aim to:
- Develop and test a community-based medication reconciliation process/intervention.
- Design and conduct a randomized controlled trial to examine the impact of the intervention on post-discharge health services utilization by comparing a set of outcome variables between intervention and non-intervention groups.
- Design a risk prediction model that helps identify patients discharged from in-patient care with the highest level of need for the intervention.
- Determine whether a community-based medication reconciliation process/intervention adds risk reduction value to individuals who have undergone an in-hospital medication reconciliation.
Study Type
Interventional
Enrollment (Actual)
156
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alberta
-
Stony Plain, Alberta, Canada, T7Z 2M7
- Westview Health Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients attending the WestView Health Centre Medicine/Family Health Unit with at least one medication at discharge.
Exclusion Criteria:
- First Nations persons
- Residents of continuing care or assisted living facilities
- Persons not residing in the Edmonton, AB, Canada region
- Persons who obtain a score of 19 or less on the Mini Mental State Examination (MMSE)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Medication Reconciliation Intervention
Participants receiving a pharmacist-led home intervention conducted within 72 hours of hospital discharge aimed at identifying and correcting medication discrepancies.
|
A pharmacist-led home intervention conducted within 72 hours of hospital discharge aimed at correcting and identifying medication discrepancies.
|
|
No Intervention: Medication Reconciliation Non-Interven.
Participants not receiving a pharmacist-led home intervention conducted within 72 hours of hospital discharge aimed at identifying and correcting medication discrepancies.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health Services Utilization 3 Months Following Hospital Discharge
Time Frame: 3 Months
|
Mean health services utilization 3 months following hospital discharge.
The specific health services utilization was re-admission to hospital, admission to home care, admission to long-term care and visits to emergency departments.
|
3 Months
|
|
Health Services Utilization 6 Months Following Hospital Discharge
Time Frame: 6 Months
|
Mean health services utilization 6 months following hospital discharge.
The specific health services utilization was re-admission to hospital, admission to home care, admission to long-term care and visits to emergency departments.
|
6 Months
|
|
Health Services Utilization 9 Months Following Hospital Discharge
Time Frame: 9 Months
|
Mean health services utilization 9 months following hospital discharge.
The specific health services utilization was re-admission to hospital, admission to home care, admission to long-term care and visits to emergency departments.
|
9 Months
|
|
Health Services Utilization 12 Months Following Hospital Discharge
Time Frame: 12 months
|
Mean health services utilization 12 months following hospital discharge.
The specific health services utilization was re-admission to hospital, admission to home care, admission to long-term care and visits to emergency departments.
|
12 months
|
|
Health Services Utilization 18 Months Following Hospital Discharge
Time Frame: 18 months
|
Mean health services utilization 18 months following hospital discharge.
The specific health services utilization was re-admission to hospital, admission to home care, admission to long-term care and visits to emergency departments.
|
18 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Allan Bailey, M.D., Westview Physician Collaborative
- Study Director: Grace Moe, M.Sc.P.T., WestView Primary Care Network
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2008
Primary Completion (Actual)
February 1, 2013
Study Completion (Actual)
February 1, 2013
Study Registration Dates
First Submitted
July 14, 2010
First Submitted That Met QC Criteria
July 15, 2010
First Posted (Estimate)
July 16, 2010
Study Record Updates
Last Update Posted (Estimate)
February 15, 2013
Last Update Submitted That Met QC Criteria
February 12, 2013
Last Verified
February 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CMPA#2026
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adverse Drug Events
-
Zhong WangShanxi Zhendong Pharmacy Co., LtdRecruitingAdverse Drug Events | Adverse Drug Reactions | Severe Adverse Events | Safety Surveillance | Severe Adverse ReactionsChina
-
Zhong WangShanxi Zhendong pharmaceutical Co. LTD.CompletedAdverse Drug Events | Adverse Drug Reactions | Severe Adverse Events | Safety Surveillance | Severe Adverse ReactionsChina
-
University of PittsburghRANDCompletedAdverse Drug EventsUnited States
-
US Department of Veterans AffairsCompletedAdverse Drug EventsUnited States
-
Indiana UniversityBrigham and Women's HospitalCompleted
-
Sultan Qaboos UniversityCompleted
-
VA Office of Research and DevelopmentCompletedAdverse Drug EventsUnited States
-
Ottawa Hospital Research InstituteMcGill University; Canadian Institutes of Health Research (CIHR)CompletedAdverse Drug EventsCanada
-
Intermountain Health Care, Inc.Completed
-
Cedars-Sinai Medical CenterNational Institutes of Health (NIH); National Institute on Aging (NIA)Completed
Clinical Trials on Medication Reconciliation
-
US Department of Veterans AffairsIcahn School of Medicine at Mount Sinai; University of VictoriaCompleted
-
VA Office of Research and DevelopmentIcahn School of Medicine at Mount Sinai; Weill Medical College of Cornell University and other collaboratorsCompleted
-
University Hospital, AkershusHospital Pharmacy Enterprise, South Eastern NorwayUnknownIntensive Care Unit | Medicines ReconciliationNorway
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceCompleted
-
University of IbadanCompletedIntervention StudyNigeria
-
Jordan University of Science and TechnologyCompletedChronic Kidney Disease(CKD)Jordan
-
University Hospital, GrenobleUnknown
-
McGill UniversityCanadian Institutes of Health Research (CIHR)CompletedAdverse Drug Events | Medication ReconciliationCanada
-
Helsinki University Central HospitalRecruitingChronic Disease | Medication Adherence | Medication NonadherenceFinland
-
Istituto Scientifico Romagnolo per lo Studio e...Completed